Health ❯ Healthcare ❯ Clinical Trials

Vaccine Trials

Triple-Negative Breast Cancer Two-Dose Regimen Ovarian Cancer Vaccine Trials Phase I Trials Allergard Vaccine Trials Safety Monitoring Efficacy Studies 21-Valent Vaccine CMV-based Vaccines Phase 3 Trials

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

Researchers will use the findings to design a Phase II efficacy trial planned for late 2026.

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

MCRI Launches World-First Infant Trial of 21‑Valent Pneumococcal Vaccine

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial